Atlas Trials

Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema

Clinical trial NCT00901186 · COMPLETED

Trial details

NCT number
NCT00901186
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Macular EdemaVisual Impairment
Start date
2009-11-01
Primary completion
2012-08-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.